Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 1,094,000 | 1,086,900 | 993,000 | 977,700 | 906,600 |
| Cost of Goods | 292,400 | 304,000 | 231,800 | 234,700 | 224,900 |
| Gross Profit | 801,600 | 782,900 | 761,200 | 743,000 | 681,700 |
| Operating Expenses | 507,700 | 515,400 | 487,800 | 749,000 | 433,700 |
| Operating Income | 294,300 | 267,500 | 274,200 | -5,300 | 248,900 |
| Interest Expense | 0 | 0 | 0 | 29,400 | 500 |
| Other Income | 7,400 | 3,800 | 3,800 | 32,900 | 300 |
| Pre-tax Income | 301,700 | 271,300 | 278,000 | -1,800 | 248,700 |
| Income Tax | 27,000 | 29,000 | 28,300 | -8,800 | 22,800 |
| Net Income Continuous | 274,700 | 242,300 | 249,700 | 7,000 | 225,900 |
| Net Income | $274,700 | $242,300 | $249,700 | $7,000 | $225,900 |
| EPS Basic Total Ops | 0.44 | 0.39 | 0.40 | 0.01 | 0.36 |
| EPS Basic Continuous Ops | 0.44 | 0.39 | 0.40 | 0.01 | 0.36 |
| EPS Diluted Total Ops | 0.43 | 0.38 | 0.39 | 0.02 | 0.35 |
| EPS Diluted Continuous Ops | 0.43 | 0.38 | 0.39 | 0.01 | 0.35 |
| EBITDA(a) | $317,400 | $289,200 | $294,800 | $14,600 | $268,100 |